ASFH Statins and Glaucoma
Guest: Joshua D. Stein, MD, MS Assistant Professor Department of Ophthalmology and Visual SciencesUniversity of MichiganAnn Arbor, MI (Source: As Seen From Here)
Source: As Seen From Here - October 6, 2012 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
#160: Statins and diabetes risk: More data; clopidogrel poststenting: The case for shorter duration, interruptions; EMA supports apixaban for AF/stroke; statins do not reduce the risk of VTE: New meta-analysis; rethinking routine testing of chest-pain pat
Statins and diabetes risk: More data; clopidogrel poststenting: The case for shorter duration, interruptions; EMA supports apixaban for AF/stroke; statins do not reduce the risk of VTE: New meta-analysis; rethinking routine testing of chest-pain patients (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - September 28, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#154: JUPITER analysis on diabetes risk with statins; statins linked to cataracts; chocolate nudges down BP in meta-analysis; bleeding risk tools compared in AF; troponin algorithm rules MI in or out in 77% of chest-pain patients
JUPITER analysis on diabetes risk with statins; statins linked to cataracts; chocolate nudges down BP in meta-analysis; bleeding risk tools compared in AF; troponin algorithm rules MI in or out in 77% of chest-pain patients (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - August 17, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#151: London 2012: Preventing SCD; CT-based FFR saves money by reducing PCIs; polypill for primary prevention: largest-yet reductions in BP, cholesterol in small trial; job stress strains women's hearts; workplace solvents linked to heart defects
London 2012: Preventing sudden cardiac death; CT-based FFR saves money by reducing PCIs; polypill for primary prevention: largest-yet reductions in BP, cholesterol in small trial; job stress strains women's hearts; workplace solvents linked to heart ... (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - July 27, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#147: No US approval yet for apixaban for stroke prevention in atrial fibrillation; FDA approves lorcaserin for the treatment of obesity; FDA refuses ACS indication for rivaroxaban—for now; Are statins less effective in women?
Published each Friday, this podcast delivers the week's five most popular articles in audio format. Stay on top of the latest cardiology news, wherever your week takes you. (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - June 29, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
#142: Statins benefit those at much lower CV risk; so long, Plavix; ARISTOTLE: Apixaban cuts stroke risk in all types of AF; Next-generation transcatheter aortic valve looks good; 2012 European HF guidelines
Statins benefit those at much lower CV risk; so long, Plavix; ARISTOTLE: Apixaban cuts stroke risk in all types of AF; Next-generation transcatheter aortic valve looks good; 2012 European HF guidelines (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - May 25, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
JAMA: 2012-04-11, Vol. 307, No. 14, Author in the Room™ Audio Interview
Interview with Rita F. Redberg, MD, author of Healthy Men Should Not Take Statins; and Michael J. Blaha, MD, MPH, author of Statin Therapy for Healthy Men Identified as "Increased Risk". Dr Redberg's Summary Points: 1. Drugs given to asymptomatic persons should either help them to feel better or live longer. 2. Statins do not meet these criterion. 3. Lifestyle is cornerstone of primary prevention. Dr Blaha's Summary Points: 1. High-quality literature supports statins for reduction of first heart attack and stroke, in addition to a mild decrease in all-cause mortality over 3 to 5 years. 2. The key to efficient use of statin...
Source: JAMA Author in the Room - May 22, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA: 2012-04-11, Vol. 307, No. 14, Author in the Room ™ Audio Interview
Interview with Rita F. Redberg, MD, author of Healthy Men Should Not Take Statins; and Michael J. Blaha, MD, MPH, author of Statin Therapy for Healthy Men Identified as "Increased Risk". Dr Redberg's Summary Points: 1. Drugs given to asymptomatic persons should either help them to feel better or live longer. 2. Statins do not meet these criterion. 3. Lifestyle is cornerstone of primary prevention. Dr Blaha's Summary Points: 1. High-quality literature supports statins for reduction of first heart attack and stroke, in addition to a mild decrease in all-cause mortality over 3 to 5 years. 2. The key to efficient use of statin...
Source: JAMA Author in the Room - May 22, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
The Lancet: May 17, 2012
Seamus Harrison discusses new research which suggests no causal link between raised HDL cholesterol and reduced risk of coronary heart disease. (Source: Listen to The Lancet)
Source: Listen to The Lancet - May 17, 2012 Category: Journals (General) Authors: The Lancet Source Type: podcasts
#136: COURAGE angle for NY analysis of PCI vs meds in stable CAD; many left ventriculographies are unnecessary; persistent high cholesterol more likely in countries with poorer healthcare; statins in primary prevention
Published each Friday, this podcast delivers the week's five most popular articles in audio format. Stay on top of the latest cardiology news, wherever your week takes you. (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - April 13, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
JAMA: 2012-04-11, Vol. 307, No. 14, Author Interview
Interview with Rita F. Redberg, MD, author of Healthy Men Should Not Take Statins (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - April 10, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA: 2012-04-11, Vol. 307, No. 14, Editor's Audio Summary
Dr Bauchner, Editor in Chief of JAMA, provides summary and commentary on the April 11, 2012 issue of JAMA, the Journal of the American Medical Association. ECG Abnormalities and CHD Event Prediction, Losartan and Heart Failure Mortality, Eliminating Waste in US Health Care, Does This Patient Have Blunt Intra-abdominal Injury?, Should healthy men take statins?, Accountable care organizations and antitrust issues. (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - April 10, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Healthy Men Should Not Take Statins
Interview with Rita F. Redberg, MD, author of Healthy Men Should Not Take Statins (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - April 10, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
#135: Analysis extends dabigatran MI signal to other thrombin inhibitors; new oral anticoagulants in AF: What to do in clinical practice; Riata ICD lead failures: Short-circuit risk; "statins for all"; biodegradable-polymer DES: Solid four-year safety and
Analysis extends dabigatran MI signal to other thrombin inhibitors; new oral anticoagulants in AF: What to do in clinical practice; Riata ICD lead failures: Short-circuit risk; "statins for all"; biodegradable-polymer DES: Solid four-year safety and (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - April 5, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
